文献速递泌尿生殖腹部MR

MR成像在膀胱癌T分期鉴别中的诊断价值:一项Meta分析

The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis.
PubMed 文献 · Radiology · 2017-12-04

该系统评价纳入17项原始诊断研究、共1449例膀胱癌患者,评估MR成像鉴别T1及以下与T2及以上肿瘤的诊断准确性。汇总敏感度为0.90(95%CI:0.83,0.94),特异度为0.88(95%CI:0.77,0.94);扩散加权成像与3 T高场强可轻度提高敏感度(0.92;95%CI:0.86,0.96)和特异度(0.96;95%CI:0.93,0.98)。

要点

  • MR鉴别膀胱癌T1及以下与T2及以上的汇总敏感度0.90、特异度0.88。
  • 采用扩散加权成像和3 T高场强时敏感度0.92、特异度0.96。
  • 共纳入17项研究、1449例膀胱癌患者,方法学质量用QUADAS-2工具评价。

核心结论

  • Meta分析显示MR成像在鉴别膀胱癌T1及以下与T2及以上肿瘤方面具有较高诊断性能,3 T高场强和扩散加权成像可轻度帮助提高敏感度和特异度。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Medline、Cochrane Library和Web of Science的原始诊断研究,最终纳入17项研究、1449例膀胱癌患者,由两名独立评价者用QUADAS-2工具评价方法学质量。

诊断标准与关键数值

  • MR鉴别T1及以下与T2及以上膀胱癌的汇总敏感度0.90(95%CI:0.83,0.94)、汇总特异度0.88(95%CI:0.77,0.94)。
  • 采用扩散加权成像和3 T高场强时敏感度0.92(95%CI:0.86,0.96)、特异度0.96(95%CI:0.93,0.98)。

临床应用与阅片要点

  • 作者结论认为MR成像对鉴别膀胱癌T1及以下与T2及以上肿瘤具有较高诊断性能。
  • 作者指出3 T高场强和扩散加权成像可轻度帮助提高敏感度和特异度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To assess the diagnostic accuracy of magnetic resonance (MR) imaging for differentiating stage T1 or lower tumors from stage T2 or higher tumors and to analyze the influence of different imaging protocols in patients with bladder cancer. Materials and Methods A systematic literature search for original diagnostic studies was performed in PubMed, Medline, the Cochrane Library, and Web of Science. The methodologic quality of each study was evaluated by two independent reviewers who used the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Data necessary to complete 2 × 2 tables were obtained, and patient, study, and imaging characteristics were extracted. Statistical analysis included data pooling, heterogeneity testing, sensitivity analyses, and forest plot construction. Results Seventeen studies (1449 patients with bladder cancer) could be analyzed. The pooled sensitivity and specificity of MR imaging were 0.90 (95% confidence interval [CI]: 0.83, 0.94) and 0.88 (95% CI: 0.77, 0.94), respectively, for differentiating tumors staged T1 or lower from those staged T2 or higher. Diffusion-weighted imaging and use of higher field strengths (3 T) improved sensitivity (0.92; 95% CI: 0.86, 0.96) and specificity (0.96; 95% CI: 0.93, 0.98). Conclusion This meta-analysis demonstrated high diagnostic performance of MR imaging for differentiating T1 or lower tumors from T2 or higher tumors in patients with bladder cancer. Higher field strength (3 T) and the use of diffusion-weighted imaging can slightly help improve sensitivity and specificity. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Huang L, Kong Q, Liu Z, et al. The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. Radiology. 2017. PMID: 29206594. doi:10.1148/radiol.2017171028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。